PL3325080T3 - Sposoby lepszego dostarczania środków czynnych do guzów - Google Patents
Sposoby lepszego dostarczania środków czynnych do guzówInfo
- Publication number
- PL3325080T3 PL3325080T3 PL16831139T PL16831139T PL3325080T3 PL 3325080 T3 PL3325080 T3 PL 3325080T3 PL 16831139 T PL16831139 T PL 16831139T PL 16831139 T PL16831139 T PL 16831139T PL 3325080 T3 PL3325080 T3 PL 3325080T3
- Authority
- PL
- Poland
- Prior art keywords
- tumors
- methods
- active agents
- better delivery
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562196578P | 2015-07-24 | 2015-07-24 | |
US201562196570P | 2015-07-24 | 2015-07-24 | |
EP16831139.7A EP3325080B1 (en) | 2015-07-24 | 2016-07-22 | Methods for better delivery of active agents to tumors |
PCT/US2016/043623 WO2017019526A2 (en) | 2015-07-24 | 2016-07-22 | Methods for better delivery of active agents to tumors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3325080T3 true PL3325080T3 (pl) | 2022-01-24 |
Family
ID=57885141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL16831139T PL3325080T3 (pl) | 2015-07-24 | 2016-07-22 | Sposoby lepszego dostarczania środków czynnych do guzów |
Country Status (15)
Country | Link |
---|---|
US (2) | US10806913B2 (pl) |
EP (2) | EP3925599A1 (pl) |
JP (1) | JP7082041B2 (pl) |
KR (1) | KR20180035209A (pl) |
CN (1) | CN107921248A (pl) |
AU (3) | AU2016297823B2 (pl) |
BR (1) | BR112018001292A2 (pl) |
CA (1) | CA2991455C (pl) |
DK (1) | DK3325080T3 (pl) |
ES (1) | ES2891523T3 (pl) |
HU (1) | HUE056410T2 (pl) |
MX (2) | MX2018000166A (pl) |
PL (1) | PL3325080T3 (pl) |
RU (1) | RU2719943C2 (pl) |
WO (1) | WO2017019526A2 (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3925599A1 (en) * | 2015-07-24 | 2021-12-22 | Sorrento Therapeutics, Inc. | Methods for better delivery of active agents to tumors |
PL3325081T3 (pl) * | 2015-07-24 | 2021-12-20 | Sorrento Therapeutics, Inc. | Sposoby dostarczania limfatycznego środków czynnych |
AU2018269544B2 (en) * | 2017-05-17 | 2024-06-13 | Massachusetts Institute Of Technology | Self-righting articles |
US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
EP3652133A4 (en) | 2017-07-10 | 2021-04-21 | Basf Se | MIXTURES INCLUDING A UREASE INHIBITOR (IU) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG) |
US11202903B2 (en) | 2018-05-17 | 2021-12-21 | Massachusetts Institute Of Technology | Systems for electrical stimulation |
CN112512502A (zh) * | 2018-05-31 | 2021-03-16 | 索伦托药业有限公司 | 靶向淋巴系统的药物输送方法 |
EP3856321A1 (en) * | 2018-09-24 | 2021-08-04 | L'oreal | Device comprising microneedles for skin-coloring |
JP2023505231A (ja) | 2019-12-05 | 2023-02-08 | ソレント・セラピューティクス・インコーポレイテッド | リンパ管送達デバイスによる抗pd-1または抗pd-l1治療剤の投与による癌の処置方法 |
EP4281167A1 (en) | 2021-01-22 | 2023-11-29 | Sorrento Therapeutics, Inc. | Device for microliter-scale lymphatic delivery of coronavirus vaccines |
WO2022192594A2 (en) | 2021-03-11 | 2022-09-15 | Sorrento Therapeutics, Inc. | Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease |
AU2022290563A1 (en) | 2021-06-09 | 2024-01-25 | Vivasor, Inc. | Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device |
CA3228858A1 (en) | 2021-08-18 | 2023-02-23 | Russell F. Ross | Therapeutic agents targeting the lymphatic system |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
KR100795870B1 (ko) * | 2000-06-01 | 2008-01-21 | 왓슨 파머수티컬즈, 인코포레이티드 | 라소폭시펜의 경피적 송달 |
MXPA04002283A (es) * | 2001-09-12 | 2004-06-29 | Becton Dickinson Co | Dispositivo de pluma a base de microaguja para el suministro de farmaco y metodo para utilizar el mismo. |
BRPI0411428A (pt) * | 2003-06-13 | 2006-07-25 | Becton Dickinson Co | distribuição intradérmica de agentes biologicamente ativos |
US20050180952A1 (en) | 2003-08-26 | 2005-08-18 | Pettis Ronald J. | Methods for intradermal delivery of therapeutics agents |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
WO2006127962A2 (en) * | 2005-05-25 | 2006-11-30 | Becton, Dickinson And Comapny | Particulate formulations for intradermal delivery of biologically active agents |
EP1893130A4 (en) * | 2005-06-17 | 2015-08-26 | Georgia Tech Res Inst | COATED MICROSTRUCTURES AND METHOD FOR THE PRODUCTION THEREOF |
US8197435B2 (en) | 2006-05-02 | 2012-06-12 | Emory University | Methods and devices for drug delivery to ocular tissue using microneedle |
EP2100850A1 (en) * | 2008-03-11 | 2009-09-16 | Stichting Voor De Technische Wetenschappen | Microneedle array and a method for manufacturing microneedles |
US8715736B2 (en) | 2009-04-30 | 2014-05-06 | Florida Agricultural And Mechanical University | Nanoparticle formulations for skin delivery |
CN101829394B (zh) * | 2010-04-27 | 2012-08-22 | 上海交通大学 | 台阶微针阵列的制备方法 |
WO2011135533A2 (en) | 2010-04-28 | 2011-11-03 | Kimberly-Clark Worldwide, Inc. | Nanopatterned medical device with enhanced cellular interaction |
US9586044B2 (en) | 2010-04-28 | 2017-03-07 | Kimberly-Clark Worldwide, Inc. | Method for increasing the permeability of an epithelial barrier |
US9522263B2 (en) | 2010-04-28 | 2016-12-20 | Kimberly-Clark Worldwide, Inc. | Device for delivery of rheumatoid arthritis medication |
CN102985131B (zh) | 2010-04-28 | 2016-06-29 | 金伯利-克拉克环球有限公司 | 用于递送siRNA的医疗装置 |
US20120187814A1 (en) | 2011-01-25 | 2012-07-26 | Fryling Nicholas A | Furniture System and a Frame Assembly for a Furniture System |
US20120245445A1 (en) * | 2011-03-21 | 2012-09-27 | Michael Darryl Black | Glucose Monitoring System |
AU2012326203B2 (en) | 2011-10-17 | 2017-11-30 | Massachusetts Institute Of Technology | Intracellular delivery |
US9550053B2 (en) | 2011-10-27 | 2017-01-24 | Kimberly-Clark Worldwide, Inc. | Transdermal delivery of high viscosity bioactive agents |
KR101575039B1 (ko) * | 2012-07-19 | 2015-12-07 | (주)아모레퍼시픽 | 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치 |
WO2014041531A1 (en) * | 2012-09-13 | 2014-03-20 | Amir Avraham | Delivery devices and methods for skin augmentation |
WO2014046983A1 (en) | 2012-09-21 | 2014-03-27 | Intensity Therapeutic | Method of treating cancer |
CN103157178B (zh) * | 2013-02-05 | 2014-12-31 | 北京化工大学 | 精确控制微针插入长度的印章式工具 |
EP2961469A4 (en) | 2013-02-28 | 2016-10-26 | Kimberly Clark Co | DEVICE FOR DELIVERY OF MEDICAMENT |
KR102295456B1 (ko) | 2013-02-28 | 2021-08-27 | 소렌토 쎄라퓨틱스, 인코포레이티드 | 경피 약물 전달 장치 |
BR112015027608A2 (pt) | 2013-05-23 | 2017-07-25 | Kimberly Clark Co | microagulhas com geometrias transversais de canal aberto melhoradas |
US10376674B2 (en) * | 2014-09-15 | 2019-08-13 | Ethicon, Inc. | System and method for targeted delivery of therapeutic agents to tissue |
PL3325081T3 (pl) * | 2015-07-24 | 2021-12-20 | Sorrento Therapeutics, Inc. | Sposoby dostarczania limfatycznego środków czynnych |
EP3925599A1 (en) * | 2015-07-24 | 2021-12-22 | Sorrento Therapeutics, Inc. | Methods for better delivery of active agents to tumors |
-
2016
- 2016-07-22 EP EP21189656.8A patent/EP3925599A1/en active Pending
- 2016-07-22 ES ES16831139T patent/ES2891523T3/es active Active
- 2016-07-22 WO PCT/US2016/043623 patent/WO2017019526A2/en active Application Filing
- 2016-07-22 CA CA2991455A patent/CA2991455C/en active Active
- 2016-07-22 HU HUE16831139A patent/HUE056410T2/hu unknown
- 2016-07-22 BR BR112018001292A patent/BR112018001292A2/pt not_active Application Discontinuation
- 2016-07-22 US US15/744,346 patent/US10806913B2/en active Active
- 2016-07-22 AU AU2016297823A patent/AU2016297823B2/en active Active
- 2016-07-22 PL PL16831139T patent/PL3325080T3/pl unknown
- 2016-07-22 EP EP16831139.7A patent/EP3325080B1/en active Active
- 2016-07-22 JP JP2018500406A patent/JP7082041B2/ja active Active
- 2016-07-22 RU RU2018104102A patent/RU2719943C2/ru active
- 2016-07-22 KR KR1020187003326A patent/KR20180035209A/ko not_active Application Discontinuation
- 2016-07-22 DK DK16831139.7T patent/DK3325080T3/da active
- 2016-07-22 MX MX2018000166A patent/MX2018000166A/es unknown
- 2016-07-22 CN CN201680042970.5A patent/CN107921248A/zh active Pending
-
2018
- 2018-01-08 MX MX2022014277A patent/MX2022014277A/es unknown
-
2020
- 2020-09-16 US US17/022,855 patent/US20210052871A1/en not_active Abandoned
-
2021
- 2021-01-12 AU AU2021200146A patent/AU2021200146B2/en active Active
-
2022
- 2022-11-21 AU AU2022275397A patent/AU2022275397A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP7082041B2 (ja) | 2022-06-07 |
AU2021200146B2 (en) | 2022-08-25 |
EP3925599A1 (en) | 2021-12-22 |
EP3325080A2 (en) | 2018-05-30 |
RU2719943C2 (ru) | 2020-04-23 |
EP3325080A4 (en) | 2019-04-17 |
US20210052871A1 (en) | 2021-02-25 |
CA2991455C (en) | 2023-10-10 |
CA2991455A1 (en) | 2017-02-02 |
BR112018001292A2 (pt) | 2018-09-11 |
US20180193624A1 (en) | 2018-07-12 |
CN107921248A (zh) | 2018-04-17 |
DK3325080T3 (da) | 2021-10-04 |
JP2018521755A (ja) | 2018-08-09 |
US10806913B2 (en) | 2020-10-20 |
WO2017019526A2 (en) | 2017-02-02 |
AU2016297823B2 (en) | 2020-10-22 |
MX2018000166A (es) | 2018-03-26 |
KR20180035209A (ko) | 2018-04-05 |
RU2018104102A (ru) | 2019-08-27 |
ES2891523T3 (es) | 2022-01-28 |
MX2022014277A (es) | 2022-12-07 |
EP3325080B1 (en) | 2021-09-01 |
AU2022275397A1 (en) | 2023-01-05 |
HUE056410T2 (hu) | 2022-02-28 |
AU2016297823A1 (en) | 2018-02-15 |
RU2018104102A3 (pl) | 2019-11-06 |
AU2021200146A1 (en) | 2021-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL291932B1 (en) | Nanoparticle preparations for prolonged treatment | |
PL3325080T3 (pl) | Sposoby lepszego dostarczania środków czynnych do guzów | |
HK1252512A1 (zh) | 向眼部遞送藥劑的方法 | |
LT3386484T (lt) | Gydomųjų medžiagų sudėtis ir pristatymo metodai | |
IL249837B (en) | An inhaler for administering active substances through the lungs | |
HK1258062A1 (zh) | 給予惡拉戈利的方法 | |
SG10201913124RA (en) | Methods for enhancing efficacy of therapeutic immune cells | |
IL250677B (en) | Cancer treatment using anti-nkg2a agents | |
ZA201506916B (en) | Microstructure array for delivery of active agents | |
IL247722A0 (en) | Pharmaceutical preparations containing active medicinal compounds for the treatment of hematological cancers | |
IL247721A0 (en) | Pharmaceutical preparations containing active medicinal compounds for the treatment of solid tumors | |
HK1245834A1 (zh) | 一種b細胞用於體內遞送治療劑 | |
IL249455A0 (en) | Complexes of mineral-amino acids with active substances | |
PL3325081T3 (pl) | Sposoby dostarczania limfatycznego środków czynnych | |
PL3021839T3 (pl) | Kompozycje do leczenia zwłóknienia | |
IL253461A0 (en) | Hydrogels for the release of therapeutic compounds | |
ZA201700518B (en) | Use of active compound compositions | |
EP3313380A4 (en) | COMPOSITION FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES TO AN ANIMAL | |
EP3094347A4 (en) | Methods for enhancing the delivery of active agents | |
PT3142641T (pt) | Formulações para o tratamento de hipertiroidismo | |
SG11201700059WA (en) | Therapeutic agent for keratoconjunctive disorder | |
IL240710A0 (en) | Administration of sdf-1 to treat ischemic tissue | |
AU2013901241A0 (en) | Composition for controlled delivery of therapeutic agents |